Downregulation of renal sodium transporters and tonicity-responsive enhancer binding protein by long-term treatment with cyclosporin A

Journal of the American Society of Nephrology

Volumn 18, Issue 2, 2007, Pages 421-429

  Sun, Woo Lim ^a   Kyung, Ohk Ahn ^b   Mee, Rie Sheen ^a   Un, Sil Jeon ^a   Kim, Jin ^b   Chul, Woo Yang ^b   Kwon, H Moo ^a,c  

^a UNIVERSITY OF MARYLAND SCHOOL OF MEDICINE   (United States)

^b The Catholic University of Korea   (South Korea)

^c Nephrology N3W143   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOSINE TRIPHOSPHATASE (POTASSIUM SODIUM); ALDEHYDE REDUCTASE; AQUAPORIN 2; ARGIPRESSIN[1 DEAMINO]; BINDING PROTEIN; CARRIER PROTEIN; CYCLOSPORIN A; SODIUM; SODIUM CHLORIDE COTRANSPORTER; SODIUM ION; SODIUM POTASSIUM CHLORIDE COTRANSPORTER; TONICITY RESPONSIVE ENHANCER BINDING PROTEIN; TRANSCRIPTION FACTOR; UNCLASSIFIED DRUG; UREA; VASOPRESSIN;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; CYTOPLASM; DOWN REGULATION; GENE EXPRESSION; GENE TARGETING; GLOMERULUS FILTRATION RATE; HYPEROSMOLALITY; KIDNEY FIBROSIS; KIDNEY FUNCTION; KIDNEY INTERSTITIUM; KIDNEY MEDULLA; KIDNEY TUBULE; MALE; NEPHROTOXICITY; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN URINE LEVEL; RAT; REGULATORY MECHANISM; RENAL PROTECTION; SALINITY; SODIUM EXCRETION;

EID: 33846683629     PISSN: 10466673     EISSN: None     Source Type: Journal    
DOI: 10.1681/ASN.2006060664     Document Type: Article

References (19)

1. Young B, Mrdmann EA, Johnson RJ, Alpers CE, Giachelli CM, Eng E, Andoh T, Bennett W, Couser WG: Cellular proliferation and macrophage influx precede interstitial fibrosis in cyclosporine nephrotoxicity. Kidney Int 48: 439-448, 1995
2. Li C, Yang CW, Park JH, Lim SW, Sun BK, Jung JY, Kim SB, Kim YS, Kim J, Bang BK: Pravastatin treatment attenuates interstitial inflammation and fibrosis in a rat model of chronic cyclosporine-induced nephropathy. Am J Physiol Renal Physiol 286: F46-F57, 2004
3. Woo SK, Dahl SC, Handler JS, Kwon HM: Bidirectional regulation of tonicity-responsive enhancer binding protein in response to changes in tonicity. Am J Physiol Renal Physiol 278: F1006-F1012, 2000
4. Jeon US, Kim JA, Sheen MR, Kwon HM: How tonicity regulates genes: Story of TonEBP transcriptional activator. Acta Physiol 187: 241-247, 2006
5. Lopez-Rodriguez C, Antos CL, Shelton JM, Richardson JA, Lin F, Novobrantseva T, Bronson RT, Igarashi P, Rao A, Olson EN: Loss of NFAT5 results in renal atrophy and lack of tonicity-responsive gene expression. Proc Natl Acad Sci U S A 101: 2392-2397, 2004
6. Lam AKM, Ko BCB, Tam S, Morris R, Yang JY, Chung SK, Chung SSM: Osmotic response element-binding protein is an essential regulator of the urine concentrating mechanism. J Biol Chem 279: 48048-48054, 2004
7. Hasler U, Jeon US, Kim JA, Mordasini D, Kwon HM, Ferille E, Martin PY: Tonicity-responsive enhancer binding protein is an essential regulator of aquaporin-2 expression in renal collecting duct principal cells. J Am Soc Nephrol 17: 1521-1531, 2006
8. Nakayama Y, Peng T, Sands JM, Bagnasco SM: The TonE/TonEBP pathway mediates tonicity-responsive regulation of UT-A urea transporter expression. J Biol Chem 275: 38275-38280, 2000
9. Sheikh-Hamad D, Nadkarni V, Choi YJ, Truong LD, Wideman C, Hodjati R, Gabbay KH: Cyclosporine A inhibits the adaptive response to hypertonicity: A potential mechanism of nephrotoxicity. J Am Soc Nephrol 12: 2732-2741, 2001
10. Jin L, Harrison SC: Crystal structure of human calcineurin complexed with cyclosporine A and human cyclophilin. Proc Natl Acad Sci U S A 99: 13522-13526, 2002
11. Lopez-Rodriguez C, Aramburu J, Rakeman AS, Rao A: NFAT5, a constitutively nuclear NFAT protein that does not cooperate with Fos and Jun. Proc Natl Acad Sci U S A 96: 7214-7219, 1999
12. Atta MG, Dahl SC, Kwon HM, Handler JS: Tyrosine kinase inhibitors and immunosuppressants perturb the myo-inositol but not the betaine cotransporter in isotonic and hypertonic MDCK cells. Kidney Int 55: 956-962, 1998
13. Lim SW, Li C, Sun BK, Han KH, Kim WY, Oh YW, Lee JU, Kador PF, Knepper MA, Sands JM, Kim J, Yang CW: Long-term treatment with cyclosporine decreases aquaporins and urea transporters in the rat kidney. Am J Physiol Renal Physiol 287: F139-F151, 2004
14. Miyakawa H, Woo SK, Dahl SC, Handler JS, Kwon HM: Tonicity-responsive enhancer binding protein, a Rel-like protein that stimulates transcription in response to hypertonicity. Proc Natl Acad Sci U S A 96: 2538-2542, 1999
15. Kim GH, Ecelbarger CA, Mitchell C, Packer RK, Wade JB, Knepper MA: Vasopressin increases Na-K-2Cl co-transporter expression in thick ascending limb of Henle's loop. Am J Physiol 276: F96-F103,1999
16. Kim GH, Masilamani S, Turner R, Mitchell C, Wade JB, Knepper MA: The thiazide-sensitive Na-Cl co-transporter is an aldosterone-induced protein. Proc Natl Acad Sci U S A 95: 14552-14557, 1998
17. Fenton RA, Chou C-L, Stewart GS, Smith CP, Knepper MA: Urinary concentrating defect in mice with selective deletion of phloretin-selective urea transporters in the renal collecting duct. Proc Natl Acad Sci U S A 101: 7469-7474, 2004
18. Lea JP, Sands JM, McMahon SJ, Tumlin JA: Evidence that the inhibition of Na+/K+-ATPase activity by FK506 involves calcineurin. Kidney Int 46: 647-652, 1994
19. Wu MS, Yang CW, Bens M, Peng KC, Yu HM, Vandervalle A: Cyclosporine stimulates Na+-K+-Cl- cotransport activity in cultured mouse medullary thick ascending limb cells. Kidney Int 58: 1652-1663, 2000